Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 95 (6) , 535-540
- https://doi.org/10.1016/s1081-1206(10)61015-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthmaJournal of Allergy and Clinical Immunology, 2003
- Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthmaThorax, 2002
- Asthma in the United States: burden and current theories.Environmental Health Perspectives, 2002
- Low-Dose Inhaled Corticosteroid Therapy and Risk of Emergency Department Visits for AsthmaArchives of internal medicine (1960), 2002
- Relationship between Asthma Drug Therapy Patterns and Healthcare UtilizationAnnals of Pharmacotherapy, 2002
- The health economics of asthma and rhinitis. I. Assessing the economic impactJournal of Allergy and Clinical Immunology, 2001
- Trends in the cost of illness for asthma in the United States, 1985-1994Journal of Allergy and Clinical Immunology, 2000
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trialJournal of Allergy and Clinical Immunology, 2000
- A National Estimate of the Economic Costs of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1997